Patients with osteoarthrosis, older than 50 years. Osteomuscular and connective tissue diseases
Conditions
Interventions
Participants, in addition to signing the ICF, will respond to a questionnaire containing socio-demographic data to characterize the population, and another questionnaire to assess pain by visual, nume
Drug
Sponsors
Universidade de Passo Fundo
Universidade de Passo Fundo
Eligibility
Inclusion criteria
Inclusion criteria: Patients over 50 years of age; Patients who self report having the diagnosis of osteoarthritis.
Exclusion criteria
Exclusion criteria: Patients who have severe cognitive disorders;cancer patients; hospital discharge for less than 30 days; or indigenous people; or have, in addition to osteoarthritis, another chronic inflammatory disease will affect the laboratory results of this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This work is expected to confirm the benefits of topical ozonated oil in the treatment of osteoarthritis. This test will be done by means of a significant decrease of p <0.05 in pre and post-intervention laboratory tests, WOMAC scale and visual pain scale, applied every 15 days during the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| How old the ozonated oil was most effective; this outcome will be evaluated by comparing the data using as the main variable the age and after seeing which group had the largest decrease in pre and post-intervention laboratory tests and a more effective clinical improvement (evaluating the WOMAC scale and visual pain scale each 15 days during the intervention). | — |
Countries
Brazil
Contacts
Public ContactAna ;Charise Anzolin;Bertol
Universidade de Passo Fundo;Universidade de Passo Fundo
Outcome results
None listed